Pharming Group Company Top Insiders
PHGUF Stock | USD 0.93 0.00 0.00% |
Pharming Group employs about 277 people. The company is managed by 8 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 34.63 employees per reported executive. Examination of Pharming Group's management performance can provide insight into the company performance.
Bruno Giannetti Executive Member of the Management Board, Chief Operations Officer |
Susanne Embleton Insider Investor Mang |
Pharming |
Pharming Group Management Team Effectiveness
The company has return on total asset (ROA) of 0.0643 % which means that it generated a profit of $0.0643 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1669 %, meaning that it generated $0.1669 on every $100 dollars invested by stockholders. Pharming Group's management efficiency ratios could be used to measure how well Pharming Group manages its routine affairs as well as how well it operates its assets and liabilities.Pharming Group Workforce Comparison
Pharming Group NV is regarded second in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 30,598. Pharming Group maintains roughly 277 in number of employees contributing less than 1% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. Pharming Group NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharming Group NV Price Series Summation is a cross summation of Pharming Group price series and its benchmark/peer.
Pharming Group Notable Stakeholders
A Pharming Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharming Group often face trade-offs trying to please all of them. Pharming Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharming Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bruno Giannetti | Member of the Management Board, Chief Operations Officer | Profile | |
Susanne Embleton | Investor Mang | Profile | |
Jeroen Wakkerman | Chief Officer | Profile | |
Ruud Outersterp | Chief Officer | Profile | |
Stephen Toor | Chief Americas | Profile | |
Anurag Relan | Chief Officer | Profile | |
MBA MD | CEO Pres | Profile | |
Mireille MSc | Chief Officer | Profile |
About Pharming Group Management Performance
The success or failure of an entity such as Pharming Group NV often depends on how effective the management is. Pharming Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharming management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharming management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Grp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 277 people.
Pharming Group Workforce Analysis
Traditionally, organizations such as Pharming Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharming Group within its industry.Pharming Group Manpower Efficiency
Return on Pharming Group Manpower
Revenue Per Employee | 605.4K | |
Revenue Per Executive | 21M | |
Net Income Per Employee | 57.7K | |
Net Income Per Executive | 2M | |
Working Capital Per Employee | 83K | |
Working Capital Per Executive | 2.9M |
Complementary Tools for Pharming Pink Sheet analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |